Connection

Dao Wang to Myocytes, Cardiac

This is a "connection" page, showing publications Dao Wang has written about Myocytes, Cardiac.
Connection Strength

0.919
  1. CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Ga12/13. J Lipid Res. 2017 07; 58(7):1338-1353.
    View in: PubMed
    Score: 0.421
  2. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin. Cardiovasc Diabetol. 2018 09 04; 17(1):123.
    View in: PubMed
    Score: 0.115
  3. Identification of cardiac long non-coding RNA profile in human dilated cardiomyopathy. Cardiovasc Res. 2018 04 01; 114(5):747-758.
    View in: PubMed
    Score: 0.112
  4. AMPKa2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation. Circ Res. 2018 03 02; 122(5):712-729.
    View in: PubMed
    Score: 0.110
  5. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy. Cell Physiol Biochem. 2017; 42(4):1645-1656.
    View in: PubMed
    Score: 0.106
  6. Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling. J Cell Physiol. 2019 07; 234(7):11587-11601.
    View in: PubMed
    Score: 0.029
  7. Loss of type 9 adenylyl cyclase triggers reduced phosphorylation of Hsp20 and diastolic dysfunction. Sci Rep. 2017 07 17; 7(1):5522.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.